Article

OptiSource to distribute lens-edge treatment pens

New York-OptiSource International has been named a master distributor of Camouflage Lens Edge Treatment Pens, which use colors and designs to make unsightly reflected light seem to disappear.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Subscribe Now!
Related Videos
Steven R. Sarkisian, Jr., MD, ABO, speaks about glaucoma at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Eric D. Donnenfeld, MD, on the effect of lifitegrast clinical signs and biomarkers in dry eye disease
(Image credit: Ophthalmology Times) The Residency Report: Clinical insights from the iStent infinite trial
(Image credit: Ophthalmology Times) ASCRS 2025: Amar Shah, MD, on why hyperosmolar tear film before and after cataract surgery matters
Related Content
Bausch + Lomb launches Blink Nourish Lubricating and Blink Boost Lubricating eye drops in US
June 6th 2025

Bausch + Lomb launches Blink Nourish Lubricating and Blink Boost Lubricating eye drops in US

3 Things You Should Know About the GA Pipeline
June 4th 2025

3 Things You Should Know About Interventional Glaucoma Comanagement

HOYA Vision Care acquires Canadian distributor Centennial Optical
June 6th 2025

HOYA Vision Care acquires Canadian distributor Centennial Optical

Patient-Centered Treatment Strategies in the Management of nAMD and DME
May 30th 2025

Patient-Centered Treatment Strategies in the Management of nAMD and DME

ViGeneron rebrands as VeonGen Therapeutics, announces rare pediatric disease designation for VG801
June 5th 2025

ViGeneron rebrands as VeonGen Therapeutics, announces rare pediatric disease designation for VG801

Ocugen signs term sheet for korean licensing of OCU400 gene therapy
June 5th 2025

Ocugen signs term sheet for korean licensing of OCU400 gene therapy

© 2025 MJH Life Sciences

All rights reserved.